This statistic depicts the share of advanced therapy trials along the drug pipeline in Italy in 2017, by type and phase. According to data, 43 percent of cellular therapy products were currently in phase I of the drug pipeline, whereas 23 percent of gene therapy products were in phase III.
Share of advanced therapy trials along the drug pipeline in Italy in 2017, by type and phase
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Quotidiano Sanità, & The European House – Ambrosetti , & Il Sole 24 Ore. (November 10, 2018). Share of advanced therapy trials along the drug pipeline in Italy in 2017, by type and phase [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/943776/clinical-development-of-advanced-therapies-in-italy/
Quotidiano Sanità, und The European House – Ambrosetti , und Il Sole 24 Ore. "Share of advanced therapy trials along the drug pipeline in Italy in 2017, by type and phase." Chart. November 10, 2018. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/943776/clinical-development-of-advanced-therapies-in-italy/
Quotidiano Sanità, The European House – Ambrosetti , Il Sole 24 Ore. (2018). Share of advanced therapy trials along the drug pipeline in Italy in 2017, by type and phase. Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/943776/clinical-development-of-advanced-therapies-in-italy/
Quotidiano Sanità, and The European House – Ambrosetti , and Il Sole 24 Ore. "Share of Advanced Therapy Trials along The Drug Pipeline in Italy in 2017, by Type and Phase." Statista, Statista Inc., 10 Nov 2018, https://www.statista.com/statistics/943776/clinical-development-of-advanced-therapies-in-italy/
Quotidiano Sanità & The European House – Ambrosetti & Il Sole 24 Ore, Share of advanced therapy trials along the drug pipeline in Italy in 2017, by type and phase Statista, https://www.statista.com/statistics/943776/clinical-development-of-advanced-therapies-in-italy/ (last visited December 22, 2024)
Share of advanced therapy trials along the drug pipeline in Italy in 2017, by type and phase [Graph], Quotidiano Sanità, & The European House – Ambrosetti , & Il Sole 24 Ore, November 10, 2018. [Online]. Available: https://www.statista.com/statistics/943776/clinical-development-of-advanced-therapies-in-italy/
